Bellicum Pharmaceuticals, Inc.
Bellicum is a clinical stage biopharmaceutical company, focused on discovering and developing novel cellular immunotherapies for the treatment of various forms of cancer. Bellicum recently completed a success IPO on the Nasdaq market and trades under the ticker symbol BLCM.
View All Investments